Ricovir EM 200 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Ricovir EM 200 mg Tablet is a fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, both nucleos(t)ide reverse transcriptase inhibitors. Its labelling describes it for the treatment of HIV infection, given alone or in combination with other antiretroviral medicines. It is described as controlling the infection rather than curing or preventing it, taken once daily at the same time each day with or without food.
Product Information
The following description reflects information associated with emtricitabine and tenofovir disoproxil fumarate and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of HIV infection, given alone or with other antiretroviral medicines
- Described as reducing the amount of HIV in the body, which is described as helping the immune system recover
- Described as neither a cure for nor a means of preventing HIV infection
Described Dosage & Administration
- Taken by mouth once daily, at about the same time each day, with or without food
- The prescriber’s instructions on dose and duration should be followed
- Tablets should be swallowed whole — not broken, chewed, or crushed
Described Side Effects
Commonly described side effects include:
- Nausea, vomiting, diarrhoea, and abdominal pain
- Headache and dizziness
- Rash
- Low or depressed mood
- Tiredness, weakness, and difficulty sleeping (insomnia)
- Abnormal dreams
- Weight loss
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Complete medical history should be shared with the doctor, in particular any liver or kidney problems or bone problems
- The medicine is described as causing drowsiness, so driving should be avoided after taking it
- Personal items such as toothbrushes and razors should not be shared, and protection should be used during sex to help prevent HIV transmission
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it combines emtricitabine and tenofovir disoproxil fumarate and is used to treat HIV infection, alone or with other antiretroviral medicines. It is described as neither a cure nor a means of preventing HIV. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth once daily at about the same time each day, with or without food, and swallowed whole. The prescriber sets the dose and duration.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.